期刊
JOURNAL OF PSYCHOPHARMACOLOGY
卷 30, 期 6, 页码 495-553出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/0269881116636545
关键词
Bipolar disorder; treatment; evidence-based guidelines; antipsychotics; antidepressants; mood stabilizers; lithium; psychoeducation; cognitive behaviour therapy
资金
- MRC [MC_UP_0901/1, G0700995, MC_U120097115] Funding Source: UKRI
- Medical Research Council [MC_UP_0901/1, MR/L010305/1, 1116129, MC_U120097115, G0700995] Funding Source: researchfish
- National Institute for Health Research [NF-SI-0510-10065, NF-SI-0513-10010] Funding Source: researchfish
The British Association for Psychopharmacology guidelines specify the scope and targets of treatment for bipolar disorder. The third version is based explicitly on the available evidence and presented, like previous Clinical Practice Guidelines, as recommendations to aid clinical decision making for practitioners: it may also serve as a source of information for patients and carers, and assist audit. The recommendations are presented together with a more detailed review of the corresponding evidence. A consensus meeting, involving experts in bipolar disorder and its treatment, reviewed key areas and considered the strength of evidence and clinical implications. The guidelines were drawn up after extensive feedback from these participants. The best evidence from randomized controlled trials and, where available, observational studies employing quasi-experimental designs was used to evaluate treatment options. The strength of recommendations has been described using the GRADE approach. The guidelines cover the diagnosis of bipolar disorder, clinical management, and strategies for the use of medicines in short-term treatment of episodes, relapse prevention and stopping treatment. The use of medication is integrated with a coherent approach to psychoeducation and behaviour change.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据